Drug Name: Tecvayli

Active Ingredient: teclistamab-cqyv

Indications: To treat relapsed or refractory multiple myeloma among adults who have received at least four specific lines of therapy

Approval Date: 10/25/2022

Company: Janssen Pharmaceutical Companies

Learn more:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761291s000lbl.pdf

Leave a Reply

Your email address will not be published. Required fields are marked *